- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Nov 8, 2024
Distillery Therapeutics
Sprayable nanorods delivering inflammasome inhibitors for psoriasis
BioCentury | Jan 28, 2020
Emerging Company Profile
Quenching the flames of inflammatory cell death
With a $50M round, Quench is developing first-in-class gasdermin D inhibitors to treat inflammatory diseases.
BioCentury | Aug 16, 2019
Targets & Mechanisms
Biotechs explore the next generation of inflammasome targets, with caution
As interest in NLRP3 grows, biotechs are looking to the next crop of inflammasome targets
BioCentury | Mar 1, 2018
Targets & Mechanisms
Checking out the microbiome
How academics are helping companies harness the microbiome for immuno-oncology
Items per page:
1 - 5 of 5